New Clox systems for rapid and efficient gene disruption in Candida albicans

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Shahana, Shahida ^a   Childers, Delma S ^a   Ballou, Elizabeth R ^a   Bohovych, Iryna ^a,b   Odds, Frank C ^a   Gow, Neil A R ^a   Brown, Alistair J P ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN TRANSPORTER; CRE RECOMBINASE; FUNGAL PROTEIN; GENETIC MARKER; INTEGRASE;

ARG4 GENE; ARTICLE; BACTERIAL GENE; CANDIDA ALBICANS; CLOX SYSTEM; CONTROLLED STUDY; CRE GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS ISOLATION; FUNGUS MUTANT; GENE CASSETTE; GENE DISRUPTION; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC MARKER; GENETIC TRANSFORMATION; HIS1 GENE; HOMOZYGOTE; INTRON; LOXP SITE; NAT1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; URA3 GENE; AMINO ACID SEQUENCE; CHEMISTRY; FUNGAL GENE; GENE DELETION; GENETIC RECOMBINATION; GENETICS; MOLECULAR GENETICS; PROCEDURES;

AMINO ACID SEQUENCE; CANDIDA ALBICANS; FUNGAL PROTEINS; GENE DELETION; GENES, FUNGAL; GENETIC ENGINEERING; GENETIC MARKERS; HOMOZYGOTE; INTEGRASES; INTRONS; MOLECULAR SEQUENCE DATA; RECOMBINATION, GENETIC;

EID: 84903289143     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100390     Document Type: Article

References (65)

1. Odds FC, Webster CE, Mayuranathan P, Simmons PD (1988) Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol 26: 277-283. (Pubitemid 19077311)
2. Calderone R (2002) Candida and candidiasis. In: Anonymous Washington, DC: ASM Press.
3. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, et al. (2012) Hidden killers: Human fungal infections. Sci Transl Med 4: 165rv13.
4. Hickman MA, Zeng G, Forche A, Hirakawa MP, Abbey D, et al. (2013) The 'obligate diploid' Candida albicans forms mating-competent haploids. Nature 494: 55-59.
5. Bennett RJ, Johnson AD (2005) Mating in Candida albicans and the search for a sexual cycle. Annu Rev Microbiol 59: 233-255. (Pubitemid 41507431)
6. Noble SM, Johnson AD (2007) Genetics of Candida albicans, a diploid human fungal pathogen. Annu Rev Genet 41: 193-211.
7. Alby K, Schaefer D, Bennett RJ (2009) Homothallic and heterothallic mating in the opportunistic pathogen Candida albicans. Nature 460: 890-893.
8. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728. (Pubitemid 23193572)
9. De Backer MD, Magee PT, Pla J (2000) Recent developments in molecular genetics of Candida albicans. Annu Rev Microbiol 54: 463-498.
10. Wilson RB, Davis D, Enloe BM, Mitchell AP (2000) A recyclable Candida albicans URA3 cassette for PCR product-directed gene disruptions. Yeast 16: 65-70. (Pubitemid 30066097)
11. Samaranayake DP, Hanes SD (2011) Milestones in Candida albicans gene manipulation. Fungal Genet Biol 48: 858-865.
12. Santos MA, Keith G, Tuite MF (1993) Non-standard translational events in Candida albicans mediated by an unusual seryl-tRNA with a 5′-CAG-3′ (leucine) anticodon. EMBO J 12: 607-616. (Pubitemid 23073707)
13. Santos MA, Tuite MF (1995) The CUG codon is decoded in vivo as serine and not leucine in Candida albicans . Nucleic Acids Res 23: 1481-1486.
14. Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, et al. (2009) Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459: 657-662.
15. Wilson RB, Davis D, Mitchell AP (1999) Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181: 1868-1874. (Pubitemid 29138620)
16. Enloe B, Diamond A, Mitchell AP (2000) A single-transformation gene function test in diploid Candida albicans. J Bacteriol 182: 5730-5736.
17. Wirsching S, Michel S, Morschhauser J (2000) Targeted gene disruption in Candida albicans wild-type strains: The role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36: 856-865. (Pubitemid 30326531)
18. Noble SM, Johnson AD (2005) Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans . Eukaryot Cell 4: 298-309. (Pubitemid 40257130)
19. Shen J, Guo W, Kohler JR (2005) CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species. Infect Immun 73: 1239-1242. (Pubitemid 40165790)
20. Boeke JD, LaCroute F, Fink GR (1984) A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 197: 345-346.
21. Wellington M, Rustchenko E (2005) 5-fluoro-orotic acid induces chromosome alterations in Candida albicans. Yeast 22: 57-70. (Pubitemid 40214405)
22. Morschhauser J, Michel S, Staib P (1999) Sequential gene disruption in Candida albicans by FLP-mediated site-specific recombination. Mol Microbiol 32: 547-556. (Pubitemid 29233899)
23. Reuss O, Vik A, Kolter R, Morschhauser J (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127. (Pubitemid 39335889)
24. Sasse C, Schillig R, Dierolf F, Weyler M, Schneider S, et al. (2011) The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans. PLoS One 6: e25623.
25. Dennison PMJ, Ramsdale M, Manson CL, Brown AJP (2005) Gene disruption in Candida albicans using a synthetic, codon-optimised cre-loxP system. Fungal Genet Biol 42: 737-748. (Pubitemid 41188172)
26. Austin S, Ziese M, Sternberg N (1981) A novel role for site-specific recombination in maintenance of bacterial replicons. Cell 25: 729-736. (Pubitemid 11022974)
27. Sternberg N, Hamilton D (1981) Bacteriophage P1 site-specific recombination. I. recombination between loxP sites. J Mol Biol 150: 467-486.
28. Sauer B (1987) Functional expression of the cre-lox site-specific recombination system in the yeast saccharomyces cerevisiae. Mol Cell Biol 7: 2087-2096.
29. Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A 85: 5166-5170.
30. Smith HA, Allaudeen HS, Whitman MH, Koltin Y, Gorman JA (1988) Isolation and characterization of a beta-tubulin gene from Candida albicans. Gene 63: 53-63. (Pubitemid 18082129)
31. Smith HA, Gorman JW, Koltin Y, Gorman JA (1990) Functional expression of the Candida albicans beta-tubulin gene in Saccharomyces cerevisiae. Gene 90: 115-123. (Pubitemid 20211891)
32. Brown AJP, Bertram G, Feldmann PJ, Peggie MW, Swoboda RK (1991) Codon utilisation in the pathogenic yeast, Candida albicans . Nucleic Acids Res 19: 4298.
33. Osborne BI, Guarente L (1989) Mutational analysis of a yeast transcriptional terminator. Proc Natl Acad Sci U S A 86: 4097-4101.
34. Barelle CJ, Manson CL, MacCallum DM, Odds FC, Gow NAR, et al. (2004) GFP as a quantitative reporter of gene regulation in Candida albicans. Yeast 21: 333-340. (Pubitemid 38425531)
35. Brand A, MacCallum DM, Brown AJP, Gow NAR, Odds FC (2004) Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 3: 900-909. (Pubitemid 39098866)
36. Inglis DO, Arnaud MB, Binkley J, Shah P, Skrzypek MS, et al. (2012) The Candida genome database incorporates multiple Candida species: Multispecies search and analysis tools with curated gene and protein information for Candida albicans and Candida glabrata. Nucleic Acids Res 40: D667-74.
37. Zeng G, Wang YM, Chan FY, Wang Y (2014) One-step targeted gene deletion in Candida albicans haploids. Nature Prot 9: 464-473.
38. Uhl MA, Biery M, Craig N, Johnson AD (2003) Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C. albicans. EMBO J 22: 2668-2678. (Pubitemid 36712364)
39. Nobile CJ, Bruno VM, Richard ML, Davis DA, Mitchell AP (2003) Genetic control of chlamydospore formation in Candida albicans. Microbiology 149: 3629-3637. (Pubitemid 38016689)
40. Roemer T, Jiang B, Davison J, Ketela T, Veillette K, et al. (2003) Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol Microbiol 50: 167-181. (Pubitemid 37222795)
41. Noble SM, French S, Kohn LA, Chen V, Johnson AD (2010) Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nature Genet 42: 590-598.
42. Xu D, Jiang B, Ketela T, Lemieux S, Veillette K, et al. (2007) Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog 3: e92.
43. Legrand M, Munro C, d'Enfert C (2012) Cool tools 5: The Candida albicans ORFeome project. in Candida and candidiasis. In: Calderone, R A. and Clancy, C J., editor. The Candida albicans ORFeome Project. In Candida and Candidiasis. Washington, DC: ASM Press. 505-510.
44. Kohler GA, White TC, Agabian N (1997) Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol 179: 2331-2338. (Pubitemid 27146889)
45. Wirsching S, Michel S, Kohler G, Morschhauser J (2000a) Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor. J Bacteriol 182: 400-404. (Pubitemid 30030124)
46. Beckerman J, Chibana H, Turner J, Magee PT (2001) Single-copy IMH3 allele is sufficient to confer resistance to mycophenolic acid in Candida albicans and to mediate transformation of clinical Candida species. Infect Immun 69: 108-114. (Pubitemid 32038305)
47. Basso LR, Bartiss A, Mao Y, Gast CE, Coelho PS, et al. (2010) Transformation of Candida albicans with a synthetic hygromycin B resistance gene. Yeast 27: 1039-1048.
48. Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, et al. (1998) Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 66: 5301-5306. (Pubitemid 29044623)
49. Bain JM, Stubberfield C, Gow NAR (2001) Ura-status-dependent adhesion of Candida albicans mutants. FEMS Microbiol Lett 204: 323-328. (Pubitemid 33145274)
50. Sundstrom P, Cutler JE, Staab JF (2002) Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect Immun 70: 3281-3283. (Pubitemid 34564194)
51. Cheng S, Nguyen MH, Zhang Z, Jia H, Handfield M, et al. (2003) Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect Immun 71: 6101-6103. (Pubitemid 37205670)
52. Murad AM, Lee PR, Broadbent ID, Barelle CJ, Brown AJP (2000) CIp10, an efficient and convenient integrating vector for Candida albicans. Yeast 16: 325-327. (Pubitemid 30105611)
53. Gerami-Nejad M, Zacchi LF, McClellan M, Matter K, Berman J (2013) Shuttle vectors for facile gap repair cloning and integration into a neutral locus in Candida albicans. Microbiology 159: 565-579.
54. Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhauser J (2000) Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci U S A 97: 6102-6107. (Pubitemid 30367530)
55. Weinberg RA, McWherter CA, Freeman SK, Wood DC, Gordon JI, et al. (1995) Genetic studies reveal that myristoylCoA:Protein N-myristoyltransferase is an essential enzyme in Candida albicans . Mol Microbiol 16: 241-250.
56. Care RS, Trevethick J, Binley KM, Sudbery PE (1999) The MET3 promoter: A new tool for Candida albicans molecular genetics. Mol Microbiol 34: 792-798.
57. Nakayama H, Mio T, Nagahashi S, Kokado M, Arisawa M, et al. (2000) Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans. Infect Immun 68: 6712-6719. (Pubitemid 32463375)
58. Park YN, Morschhauser J (2005) Tetracycline-inducible gene expression and gene deletion in Candida albicans. Eukaryot Cell 4: 1328-1342.
59. Gerami-Nejad M, Berman J, Gale CA (2001) Cassettes for PCR-mediated construction of green, yellow, and cyan fluorescent protein fusions in Candida albicans. Yeast 18: 859-864. (Pubitemid 32633521)
60. Blackwell C, Russell CL, Argimon S, Brown AJP, Brown JD (2003) Protein A-tagging for purification of native macromolecular complexes from Candida albicans. Yeast 20: 1235-1241. (Pubitemid 37461360)
61. Nagy A (2000) Cre recombinase: The universal reagent for genome tailoring. Genetics 26: 99-109.
62. Staib P, Kretschmar M, Nichterlein T, Kohler G, Michel S, et al. (1999) Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol 32: 533-546. (Pubitemid 29233898)
63. Sherman F (1991) Getting started with yeast. Methods Enzymol 194: 3-21.
64. Sanglard D, Ischer F, Monod M, Bille J (1996) Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob Agents Chemother 40: 2300-2305. (Pubitemid 26328036)
65. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182. (Pubitemid 15180998)